City of Hope – The first patient to receive City of Hope’s novel, promising cancer medicine AOH1996 is doing well

LOS ANGELES — City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced that the first patient to receive its novel, promising cancer medicine AOH1996 is doing well. The Phase 1 clinical trial testing the safety of a potentially cancer-stopping therapeutic developed by City of Hope in…

Read More

Aspirin and Cancer: the Emerging Evidence

Professor Peter Elwood Honorary Professor, Cardiff University There is a remarkable harmony between the effects of aspirin on the biological mechanisms of cancer metabolism and growth, and clinical evidence of reductions in cancer mortality and metastatic cancer spread. Although aspirin increases the number of bleeds, the severity of bleeds attributable to aspirin is low, and…

Read More

Ancient Chinese medicine unlocks new possibilities for cancer treatment

Ancient Chinese medicine unlocks new possibilities for cancer treatment After 20 years of research, Yale pharmacologist Yung-Chi Cheng and his partners are launching the first international clinical trial for a botanical drug. More than 20 years ago, Yale pharmacology professor Yung-Chi Cheng, a leader in drug development for hepatitis B, cancer, and HIV, had a…

Read More